DULAGLUTIDE AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES (REWIND): A DOUBLE-BLIND, RANDOMISED PLACEBO-CONTROLLED TRIAL СтатьяGerstein H.C., Dyal L., Hall S., Rao-Melacini P., Wong G., Colhoun H.M., Dagenais G.R., Diaz R., Lakshmanan M., Riesmeyer J.S., Atisso C.M., Pais P., Xavier D., Probstfield J., Riddle M.C., Rydén L., Avezum A., Basile J., Chung N., Conget I. ...Lancet. Том 394. 2019. С. 121-130
PRE-DISCHARGE ANEMIA AS A PREDICTOR OF ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE СтатьяKim M.C., Kim K.H., Cho J.Y., Lee K.H., Sim D.S., Yoon H.J., Yoon N.S., Hong Y.J., Park H.W., Kim J.H., Ahn Y., Jeong M.H., Cho J.G., Park J.C.The Korean Journal of Internal Medicine. Том 34. 2019. С. 549-558
